A Mumbai-based pharmaceutical company Medley Pharma is up for sale and is expected to be sold for Rs 5,000 crore in a deal. According to a report in Times of India, drug giants Cipla, Dr Reddy's Lab, JB Chemicals, and Torrent, as well as prominent private equity firms Advent, Carlyle, and Blackstone, are all interested in buying the Rs 1,000-crore business.
- Read more about Medley Pharma will be expected to sell for Rs 5,000 crore
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/medley-pharma-will-be-expected-to-sell
No comments:
Post a Comment